PROPANC BIOPHARMA, INC. Stock Issued During Period, Shares, Restricted Stock Award, Gross
PROPANC BIOPHARMA, INC. (PPCB) reported Stock Issued During Period, Shares, Restricted Stock Award, Gross of 78 shares for the 1-month period ending 2019-05-31, per its 10-K filed 2021-09-28.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement
us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross · last filed 2021-09-28
- 2019-05-31: Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month 78.00 shares; Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month as first filed 78.00K shares.
- 2017-12-29: Stock Issued During Period, Shares, Restricted Stock Award, Gross 0 month 500.00K shares.
| Period end | Stock Issued During Period, Shares, Restricted Stock Award, Gross 0 month | Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month | Stock Issued During Period, Shares, Restricted Stock Award, Gross 1 month as first filed |
|---|---|---|---|
| 2019-05-31 | 78.00 shares 10-K · filed 2021-09-28 | 78.00K shares 10-Q · filed 2019-11-14 | |
| 2017-12-29 | 500.00K shares 10-K · filed 2018-09-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |